To explore the clinical efficacy of acupoint catgut embedding combined with proton pump inhibitors in the treatment of chronic non-atrophic gastritis.Methods：A total of 200 patients with chronic non-atrophic gastritis admitted to Langfang People's Hospital from January 2016 to December 2018 were selected as the research objects.They were randomly divided into control group and observation group with 100 cases in each group by random number table method.The control group was treated with omeprazole enteric-coated tablets orally,while the observation group was treated with omeprazole enteric-coated tablets orally combined with acupoint catgut embedding.The therapeutic effects of the 2 groups were observed and analyzed.Results：The total effective rate was 89% in the observation group and 67% in the control group.The cure rate of symptoms in the observation group was significantly higher than that in the control group.There was a significant difference between the 2 groups(P<0.05).Comparedtheefficacy of therapeutic endoscopy,the total effective rate was 88.00% in the observation group and 77% in the control group.There was significant difference between the 2 groups(P<0.05).Observed the side effects,the incidence of side effects was 13.00% in the observation group and 8.00% in the control group.There was no significant difference between the 2 groups(P>0.05).Conclusion：Acupoint catgut embedding combined with proton pump inhibitor is effective in treating chronic non-atrophic gastritis,with a higher cure rate and better improvement of symptoms.